Opportunity Information: Apply for CDC RFA GH15 1595
Apply for CDC RFA GH15 1595
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Partnering with Pasteur Institute of Ho Chi Minh City to Enhance Regional Capacity to Prevent, Detect, Monitor, and Respond to the HIV/AIDS Epidemic in Vietnam under the Presidents Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Dec 1, 2014 and posted on Dec 1, 2014.
- Applicants must submit their applications by Jan 23, 2015 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $800,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $4,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Pasteur Institute of Ho Chi Minh City
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity (CDC RFA GH15-1595) is a PEPFAR-funded cooperative agreement designed to strengthen Vietnam's HIV/AIDS response in the southern region by improving two core capabilities inside government health facilities: laboratory quality management and surveillance/strategic information systems. The underlying problem the FOA is trying to solve is that many facilities across the regional, provincial, district, and commune levels still need stronger systems to generate reliable HIV diagnostic results and to turn routine program and surveillance data into timely, actionable information for decision-making. Without consistent quality assurance, standardized procedures, and well-managed data systems, gaps show up in testing accuracy, result reporting, case reporting, and broader surveillance, which ultimately weakens Vietnam's ability to monitor the epidemic and respond effectively.
The opportunity is structured around Vietnam's public health governance and how HIV services and data flow through it. The Ministry of Health (MOH) oversees several key bodies: the General Department of Preventive Medicine (GDPM), which supervises regional institutes and preventive medicine centers (PMCs); the Vietnam Administration of HIV/AIDS Control (VAAC), which supervises provincial AIDS committees (PACs); and the Vietnam Administration for Medical Services (VAMS), which supervises central and regional hospitals. The FOA notes that PMCs, PACs, and key hospitals are all important nodes in the national HIV system, but they require targeted technical assistance to improve system management, quality assurance and quality control, and workforce capacity. The idea is that improvements at these points will translate into better diagnostic capacity at facilities, more complete and accurate case reporting, and stronger surveillance outputs across the region.
A central feature of the announcement is the role of the Pasteur Institute of Ho Chi Minh City as the technical partner. Because the Pasteur Institute is a regional public health institution that reports directly to the MOH, it is positioned to provide hands-on technical assistance to government health facilities and to support standardization across jurisdictions. The FOA frames the Pasteur Institute's contribution as building the capacity of both systems and staff to monitor and respond to HIV/AIDS, aligning technical work with Vietnam's strategic direction for HIV and other public health conditions. In practice, this means mentoring, training, system strengthening, and establishing or reinforcing operational processes that make labs and data systems function consistently and transparently over time, rather than relying on ad hoc fixes.
The program goals are explicitly tied to Vietnam's National Strategy for HIV/AIDS through 2020. Two priorities are emphasized. First is building and strengthening national surveillance data systems that can collect and report timely, high-quality data, and then actually use those data to measure performance in HIV prevention and in care and treatment programs. This is the "strategic information" side of the FOA: improving how data are captured, verified, analyzed, and used so that program managers and policymakers can track trends, identify gaps, and adjust interventions quickly. Second is strengthening regional laboratory capacity so that HIV diagnostic testing is accurate and reliable, results are appropriately disseminated, and continuous quality improvement efforts are built into routine operations to support disease detection, monitoring, and surveillance.
The timing and framing also reflect PEPFAR's broader shift during its third five-year phase toward deeper technical assistance and sustainability. Rather than focusing primarily on direct service delivery expansion, the FOA highlights the need to strengthen facility systems and staff capacity so that Vietnam can produce high-quality diagnostic, monitoring, and surveillance data that support decision-making. The expected benefit is a national HIV/AIDS response that is more accurate, reliable, and efficient, with improved confidence in lab results and improved credibility and usefulness of surveillance and program data for guiding resources and interventions.
Administratively, this is a discretionary funding opportunity using a cooperative agreement mechanism, meaning CDC anticipates substantial involvement in the program's implementation and oversight rather than simply issuing a grant with minimal federal engagement. The FOA was posted December 1, 2014, with an application due date of January 23, 2015, and an archive date of February 22, 2015. It anticipated a single award (ExpectedAwards: 1). The estimated total funding listed is $800,000, with an award floor of $800,000 and an award ceiling of $4,000,000, and there is no cost-sharing or matching requirement. Eligibility is effectively limited to the Pasteur Institute of Ho Chi Minh City, as stated in the eligibility information. The funding is associated with CFDA 93.067 (Global AIDS), and the sponsoring agency is the Centers for Disease Control and Prevention (CDC). The listed project officer contact is Marta Ackers (mda6@cdc.gov).
Frequently Asked Questions (FAQs): CDC RFA GH15-1595 (Vietnam HIV/AIDS Systems Strengthening)
1) What is CDC RFA GH15-1595?
CDC RFA GH15-1595 is a PEPFAR-funded cooperative agreement intended to strengthen Vietnam's HIV/AIDS response in the southern region by improving two core capabilities within government health facilities: (1) laboratory quality management and (2) surveillance/strategic information systems.
2) What problem is this funding opportunity trying to solve?
The funding opportunity targets persistent system gaps across regional, provincial, district, and commune levels where facilities still need stronger processes to produce reliable HIV diagnostic results and to convert routine program and surveillance data into timely, actionable information for decision-making. The FOA emphasizes that weaknesses in quality assurance, standardized procedures, and data management can lead to gaps in testing accuracy, result reporting, case reporting, and broader surveillance outputs.
3) What are the two main technical focus areas of the program?
The opportunity focuses on improving:
- Laboratory quality management, to ensure HIV diagnostic testing is accurate and reliable and to embed continuous quality improvement into routine operations.
- Surveillance and strategic information systems, to strengthen how HIV-related data are collected, verified, analyzed, reported, and used to guide program performance and decision-making.
4) What does "strategic information" mean in this FOA?
In this FOA, "strategic information" refers to strengthening surveillance and routine program data systems so they can produce timely, high-quality data and support the actual use of those data to measure and manage performance in HIV prevention and in care and treatment programs. This includes improving data capture, verification, analysis, reporting, and use.
5) Which part of Vietnam is the program intended to support?
The FOA is designed to strengthen Vietnam's HIV/AIDS response in the southern region, primarily through improvements implemented within government health facilities and the systems that connect them.
6) How does the FOA describe Vietnam's HIV governance and service/data flow?
The FOA frames the program around Vietnam's public health governance structure, highlighting the Ministry of Health (MOH) and its oversight of key bodies that shape HIV services and data flows:
- General Department of Preventive Medicine (GDPM), which supervises regional institutes and preventive medicine centers (PMCs).
- Vietnam Administration of HIV/AIDS Control (VAAC), which supervises provincial AIDS committees (PACs).
- Vietnam Administration for Medical Services (VAMS), which supervises central and regional hospitals.
7) Which types of government health entities are highlighted as key "nodes" in the national HIV system?
The FOA emphasizes the role of preventive medicine centers (PMCs), provincial AIDS committees (PACs), and key hospitals as important nodes that contribute to diagnostic capacity, case reporting, and surveillance. These entities are identified as needing targeted technical assistance to strengthen system management, quality assurance/quality control, and workforce capacity.
8) Who is the central technical partner identified in the announcement?
The FOA identifies the Pasteur Institute of Ho Chi Minh City as the central technical partner. The Institute is described as a regional public health institution that reports directly to the MOH and is positioned to provide hands-on technical assistance to government health facilities and support standardization across jurisdictions.
9) What kind of support is expected from the Pasteur Institute of Ho Chi Minh City?
Based on the FOA description, the Pasteur Institute's expected role includes hands-on technical assistance to strengthen both systems and staff capacity. The FOA references activities such as mentoring, training, system strengthening, and establishing or reinforcing operational processes so that laboratories and data systems function consistently and transparently over time (as opposed to relying on ad hoc fixes).
10) How is the program aligned with Vietnam's national HIV strategy?
The FOA ties the program goals to Vietnam's National Strategy for HIV/AIDS through 2020, emphasizing two priorities: building/strengthening national surveillance data systems for timely, high-quality data and strengthening regional laboratory capacity for accurate and reliable HIV diagnostic testing.
11) What outcomes does the FOA expect from strengthening laboratory systems?
The FOA expects that strengthening laboratory systems will improve the accuracy and reliability of HIV diagnostic testing, support appropriate dissemination of results, and embed continuous quality improvement in routine operations. These changes are intended to support disease detection, monitoring, and surveillance.
12) What outcomes does the FOA expect from strengthening surveillance and data systems?
The FOA expects improved completeness, accuracy, timeliness, and usefulness of HIV surveillance and routine program data. Better data systems are intended to produce actionable information for managers and policymakers to track trends, identify gaps, and adjust interventions and resources quickly.
13) What is a cooperative agreement, and what does it imply for this opportunity?
This opportunity uses a cooperative agreement mechanism, which the FOA describes as involving substantial CDC involvement in implementation and oversight. In other words, CDC is expected to be actively engaged rather than providing funding with minimal federal involvement.
14) How does the FOA relate to PEPFAR's broader direction at the time?
The FOA reflects PEPFAR's shift during its third five-year phase toward deeper technical assistance and sustainability. Rather than focusing mainly on expanding direct service delivery, the FOA emphasizes strengthening facility systems and staff capacity so Vietnam can produce high-quality diagnostic and surveillance information to support decision-making.
15) What is the CFDA number associated with this funding?
The FOA is associated with CFDA 93.067 (Global AIDS).
16) Which agency is sponsoring this funding opportunity?
The sponsoring agency is the Centers for Disease Control and Prevention (CDC).
17) What is the total estimated funding amount listed in the FOA?
The FOA lists an estimated total funding amount of $800,000.
18) What are the award floor and award ceiling?
The FOA lists an award floor of $800,000 and an award ceiling of $4,000,000.
19) How many awards were anticipated?
The FOA anticipated one award (ExpectedAwards: 1).
20) Is cost-sharing or matching required?
No. The FOA states there is no cost-sharing or matching requirement.
21) Who is eligible to apply for this opportunity?
Eligibility is effectively limited to the Pasteur Institute of Ho Chi Minh City, as stated in the eligibility information provided in the FOA summary.
22) When was the FOA posted, and what were the key dates?
The FOA was posted on December 1, 2014. The application due date was January 23, 2015, and the archive date was February 22, 2015.
23) What is the official opportunity identifier mentioned?
The opportunity is identified as CDC RFA GH15-1595.
24) Who is the listed CDC project officer contact?
The listed project officer is Marta Ackers, and the email provided is mda6@cdc.gov.
25) What types of improvements does the FOA suggest are needed at facility and system levels?
The FOA points to needs such as consistent quality assurance and quality control, standardized procedures, improved system management, stronger workforce capacity, and better-managed data systems. The intent is for these improvements to reduce gaps in testing accuracy and reporting and to strengthen surveillance and program monitoring outputs across the region.
26) What is the long-term intent described by the FOA?
The FOA emphasizes sustainability through strengthening routine operations: building processes and staff capacity so laboratories and data systems function consistently over time. The expected benefit is a more accurate, reliable, and efficient national HIV/AIDS response with greater confidence in lab results and greater credibility and usefulness of surveillance and program data.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Entrepreneurship Programs
Previous opportunity: Improving Evaluation Capacity within the Government of Tanzania under the Presidents Emergency Plan for AIDS Relief (PEPFAR)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH15 1595
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH15 1595) also looked into and applied for these:
| Funding Opportunity |
|---|
| Statewide Family Network Program Apply for SM 15 001 Funding Number: SM 15 001 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $95,000 |
| Statewide Consumer Network Program Apply for SM 15 002 Funding Number: SM 15 002 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $95,000 |
| Service Area Competition Additional Areas (SAC AA) Green Valley, AZ Wichita, KS Franklin, NH Washington, NC and Cheyenne, WY Apply for HRSA 15 139 Funding Number: HRSA 15 139 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Human Cellular Models for Predicting Individual Responses to Cystic Fibrosis Transmembrane Conductance Regulator Directed Therapeutics (R41) Apply for RFA HL 15 026 Funding Number: RFA HL 15 026 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Human Cellular Models for Predicting Individual Responses to Cystic Fibrosis Transmembrane Conductance Regulator Directed Therapeutics (R43/R44) Apply for RFA HL 15 027 Funding Number: RFA HL 15 027 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| High Priority Immunology Grants (R01) Apply for PAS 15 055 Funding Number: PAS 15 055 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Perinatal and Infant Oral Health Quality Improvement Expansion Grant Program Apply for HRSA 15 070 Funding Number: HRSA 15 070 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Advanced Nursing Education Program Apply for HRSA 15 046 Funding Number: HRSA 15 046 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Unconventional Roles of Ethanol Metabolizing Enzymes, Metabolites, and Cofactors in Health and Disease (R21) Apply for PA 15 057 Funding Number: PA 15 057 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Unconventional Roles of Ethanol Metabolizing Enzymes, Metabolites, and Cofactors in Health and Disease (R01) Apply for PA 15 058 Funding Number: PA 15 058 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCR Clinical Trial or Biomarker Clinical Validation Study Cooperative Agreement (U01) Apply for PAR 15 059 Funding Number: PAR 15 059 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Predoctoral Training in General, Pediatric and Public Health Dentistry and Dental Hygiene Apply for HRSA 15 050 Funding Number: HRSA 15 050 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Asthma Empowerment Collaborations to Reduce Childhood Asthma Disparities (U01) Apply for RFA HL 17 001 Funding Number: RFA HL 17 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Epi Centers for the Prevention of Healthcare Associated Infections, Antimicrobial Resistance and Adverse Events A Multicenter Program Expansion (U54) Apply for RFA CK 11 0010501SUPP15 Funding Number: RFA CK 11 0010501SUPP15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $800,000 |
| Creating Asthma Empowerment Collaborations to Reduce Childhood Asthma Disparities (U34) Apply for RFA HL 15 028 Funding Number: RFA HL 15 028 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Radiological/Nuclear Medical Countermeasure Product Development Program (R43/R44) Apply for PA 15 065 Funding Number: PA 15 065 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Postdoctoral Training in General, Pediatric, and Public Health Dentistry Apply for HRSA 15 051 Funding Number: HRSA 15 051 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Nurse Anesthetist Traineeship Program (NAT) Apply for HRSA 15 047 Funding Number: HRSA 15 047 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Innovation Grants to Nurture Initial Translational Efforts (IGNITE) Assay Development and Therapeutic Agent Identification and Characterization to Support Therapeutic Discovery (R21/R33) Apply for PAR 15 070 Funding Number: PAR 15 070 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Innovation Grants to Nurture Initial Translational Efforts (IGNITE) Pharmacodynamics and In vivo Efficacy Studies for Small Molecules and Biologics/Biotechnology Products (R21/R33) Apply for PAR 15 071 Funding Number: PAR 15 071 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH15 1595", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.